News
La directora científica del IDIS, Mª Luz Couce Pico, recibe el XXIII Premio Nóvoa Santos
La Asociación de Médicos Gallegos distingue la labor de la directora científica del IDIS como el máximo exponente de la neonatología gallega.
DIVERSA Biotechnologies has concluded its capital expansion with Sémola Tech Ventures SL, Volsunga SL, Janus Projects SL, and UNIRISCO.
The spin-off of the Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS) and SERGAS, specialized in nanomedicine, aims to have an impact on the development of innovative drugs, specifically in the areas of oncology and rare diseases, but also in many others due to its collaborative business model.
La investigadora del IDIS, Ana Belén Cid Álvarez, recibe el V Premio Ramiro Carregal de Cardiología
El estudio premiado aborda el desarrollo de modelos predictivos para mejorar el pronóstico y el tratamiento de la insuficiencia mitral severa, la valvulopatía más común entre mayores de 75 años
Calendar
COMMON SUPPORT PLATFORMS
The platforms are research support units featured by a high strategic value, equipped by cutting edge technologies and operated by highly specialised technical staff.
CALLS
All updated information on public and private competitive calls. The most convenient and safest way to send your requests.
CAREERS
Would you like to join our team? We are always looking for people with a passion for research and propelled by insatiable curiosity to join our mission of providing a better healthcare day every day. Here you can see and apply for our current vacancies.
Research Areas
ONCOLOGY
Improvement of treatments: personalised therapy and reduction of side effects.
GENETICS AND SYSTEMS BIOLOGY
Identification of genetic biomarkers of disease susceptibility and prognosis
ENDOCRINOLOGÍA, NUTRICIÓN Y METABOLISMO
The area studies obesity from different perspectives with the participation of groups from the clinical and basic fields in a synergistic way.
NEUROSCIENCES
Search for new therapeutic targets and improvement of the clinical-therapeutic management of neurological patients, mainly stroke, Alzheimer’s, Parkinson’s disease, headaches and neurological diseases caused by prions.
CARDIOVASCULAR
The general objective of the Cardiovascular Area consists of the search for new therapeutic targets and the improvement of clinical-therapeutic management.
PLATFORMS AND METODOLOGY
The area aims at providing evidence for prioritising the management of public resources, evaluating risks and identifying opportunities for improving the health of the population. From here, prioritise structural investments and action programs.
Area Coordinator A007 - Infectology, Inflammation and Vaccines. Lead researcher of the group C020 - Genetics, Vaccines, Infections and Paedriatics (GENVIP)
Scientific Director of the IDIS - Lead Researcher of group C012 - Metabolic Disorders
Area Coordinator A001 - Oncology. Lead Researcher of the group C030 - Translational Medical Oncology
Area Coordinator A002 - Genetics and Systems Biology. Lead Researcher of the group C002 - Genetics
Leader Area A003 - Endocrinology, nutrition and metabolism. Leader of group C006 - Molecular endocrinology
Area Coordinator A005 - Platforms and Methodology. Lead Researcher of group C015 - Research Methodology
Area Coordinator A006 - Cardiovascular. Lead Researcher of group C016 - Cardiology
Area Coordinator A004 - Neurosciences. Lead researcher of group C018 - Experimental Neurology of Parkinson's Disease
